← Eichor
Study identifier: NCT06629389 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms

Condition: Parkinson Disease  ·  Sponsor: Laboratorio Elea Phoenix S.A.

PhasePhase 2
Planned participants88
Who can joinAll sexes, 40 Years to 80 Years
Healthy volunteersNo

About this study

Parkinson disease (PD) is a chronic, progressive neurodegenerative disorder characterized by clinical motor and non-motor symptoms. Knowing the potential benefits has led to the use of cannabis as an alternative therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Maria Daniela Di Leo, MD  ·  1144898300  ·  daniela.dileo@elea.com

Marcelo A Tinelli, MD  ·  1144898300  ·  marcelo.tinelli@elea.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital Español de MendozaMendoza, Mendoza Province, ArgentinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06629389